The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation.
about
Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral AnticoagulantsAsian strategy for stroke prevention in atrial fibrillationCardiovascular risk profile and management of atrial fibrillation in India: Real world data from RealiseAF surveyAn Observational, Prospective Survey Assessing the Control of Atrial Fibrillation in Asia Pacific: Rationale and Design of the RecordAF-AP Registry.New-onset atrial fibrillation is a predictor of subsequent hyperthyroidism: a nationwide cohort study.Trends in US hospitalization rates and rhythm control therapies following publication of the AFFIRM and RACE trialsContemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches?Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registryAn International Observational Prospective Survey Assessing the Control of Atrial Fibrillation in Asia-Pacific: Results of the Record-AFAP Registry.Atrial Fibrillation Management Strategies in Routine Clinical Practice: Insights from the International RealiseAF SurveyClinical Differences between Subtypes of Atrial Fibrillation and Flutter: Cross-Sectional Registry of 407 Patients.Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).Effects of pharmacologic therapy on health-related quality of life in elderly patients with atrial fibrillation: a systematic review of randomized and nonrandomized trials.Pharmacotherapy in Medicare beneficiaries with atrial fibrillation.Current management of atrial fibrillation: an observational study in NHS primary care.Avoiding permanent atrial fibrillation: treatment approaches to prevent disease progression.Demographic Characteristics and Patterns of Medication in Atrial Fibrillation Patients in South West Ontario: Insights from a Large Primary Care Database.Clinical characteristics, management, and control of permanent vs. nonpermanent atrial fibrillation: insights from the RealiseAF survey.Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities (ARIC) Study.Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications.Advances in catheter ablation: atrial fibrillation ablation in patients with mitral mechanical prosthetic valve.Epidemiology of classical risk factors in stroke patients in the Middle East.Management of patients with atrial fibrillation by primary-care physicians in Germany: 1-year results of the ATRIUM registry.Gender differences in patients with atrial fibrillation.A Prospective Survey of Atrial Fibrillation Management for Real-world Guideline Adherence: COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) Registry.The Cumulative Incidence of Stroke, Myocardial infarction, Heart Failure and Sudden Cardiac Death in Patients with Atrial Fibrillation.Association between connexin 40 and potassium voltage-gated channel subfamily A member 5 expression in the atrial myocytes of patients with atrial fibrillation.The Impact of Risk Factors and Comorbidities on The Incidence of Atrial Fibrillation.Baseline characteristics and management of patients with atrial fibrillation/flutter in the emergency department: results of a prospective, multicentre registry in China.Should atrial fibrillation patients with hypertension as an additional risk factor of the CHA2DS2-VASc score receive oral anticoagulation?Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
P2860
Q26750467-92E598E5-CA82-4926-B559-B668DFB8DBBFQ28072723-B91B540D-982A-43D8-89A8-D28342B30BF8Q31138544-7257F010-CACB-4687-AEA0-2D6A71F7F798Q34583506-4BECB436-5934-45C2-A540-4B62F96B2F07Q34612593-305A3A99-AB4F-4E97-9D31-804E7075C2EFQ34694265-8C68E4E6-D1EA-4F24-8464-723DB36CC41EQ35026442-701EEA1A-E003-4967-B269-A4A526A66312Q35226363-106E8E75-363B-4B6E-BF5C-D3CD6B090431Q35897223-5332296E-A74C-4F97-9782-62B627A4F69CQ35901629-F2B6123A-BE90-4125-84A0-557A7C7BFA99Q35911610-CA3B0134-31CE-4DB9-882A-6791918706A1Q36141391-5BE0BB2E-C56B-44DD-98A9-57570B60DF65Q36584622-C590A890-37A8-4D51-99E4-1CA5D0F46565Q36838560-5AFE6AA1-89D8-4AB2-8F59-BA6DA8ECCD4DQ37342387-724C4773-9025-4CAD-878D-FD8D1D82192EQ37412467-CB3BE47B-4C9C-4DA6-BEF4-3081DA54DAF1Q37496201-8C800FE0-9B97-4BF3-A8B6-36B6CB90209BQ37538004-68F9B4C2-4639-477F-8B44-A38F4C3AE537Q37696652-340B526A-EA53-4576-B450-77C7D37FAB32Q37963121-E6488A35-F22A-42A5-9958-097A71B38008Q38045927-AC1675DE-6A61-440E-B1BF-2D185F553979Q38515153-A658B37E-58AE-4831-846B-3AAD7D13D40EQ43788136-3E6AC220-F444-4F23-B3B8-47DA7BCB7E7EQ44105556-3EF2A8F8-0361-4BB7-9391-3873B7171C62Q47094449-F97C5E64-9C15-4B21-81EB-DDDB6CC56833Q47097967-A7536C9E-1188-4716-B22F-16503F58B1F1Q47142479-37909ACC-3307-4CF0-82FB-EEE3E97E8B21Q49746179-20995809-F2DA-485C-85C9-770C6010C871Q51136344-275F6A24-E322-47FD-8BCD-D766437135D5Q55398440-99AFF70B-AAA4-43E4-8FCB-ADFD58A37E18Q57313061-8E47741A-8508-40BE-BE1E-0B822C88B244
P2860
The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The RecordAF study: design, ba ...... ategy for atrial fibrillation.
@ast
The RecordAF study: design, ba ...... ategy for atrial fibrillation.
@en
The RecordAF study: design, ba ...... ategy for atrial fibrillation.
@nl
type
label
The RecordAF study: design, ba ...... ategy for atrial fibrillation.
@ast
The RecordAF study: design, ba ...... ategy for atrial fibrillation.
@en
The RecordAF study: design, ba ...... ategy for atrial fibrillation.
@nl
prefLabel
The RecordAF study: design, ba ...... ategy for atrial fibrillation.
@ast
The RecordAF study: design, ba ...... ategy for atrial fibrillation.
@en
The RecordAF study: design, ba ...... ategy for atrial fibrillation.
@nl
P2093
P50
P1476
The RecordAF study: design, ba ...... ategy for atrial fibrillation.
@en
P2093
Eric N Prystowsky
Harry Crijns
Ihsen Merioua
Jean-Yves Le Heuzey
Paul Dorian
Peter R Kowey
William Weintraub
P304
P356
10.1016/J.AMJCARD.2009.10.012
P407
P577
2009-12-07T00:00:00Z